CRSP logo

CRISPR Therapeutics AG (CRSP) P/E ratio

PE ratio:

N/A
September 10, 2025

Summary

  • CRSP price to earnings ratio is not available.

Performance

CRSP PE ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

OtherCRSPvaluation metrics

PE ratio Formula

P/E =  
Price
TTM Earnings Per Share

CRSP PE ratio Trends

PeriodPeriodPE ratioPE ratioPricePriceTTM EPSTTM EPSTTM revenueTTM revenue
todaytoday--3.5%-20.2%+1.0%
1 m1 month--5.8%--
3 m3 months-+20.7%-20.2%+1.0%
6 m6 months-+19.5%--
ytdytd-+31.6%--
1 y1 year-+13.6%-67.5%-81.2%
5 y5 years--36.7%-1276.1%-86.8%

CRSP PE ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month
3 m3-month
6 m6-month
1 y1-year
3 y3-year
5 y5-year193.0711.98
alltimeall time218.784.44

CRSP PE ratio History

DateValue
2021
17.14(-72.7%)
DateValue
2019
62.79(+759.0%)
2016
7.31

FAQ

  • What is the all time high PE ratio for CRISPR Therapeutics AG?

What is the all time high PE ratio for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high price to earnings ratio is 218.78
On this page